SL Science Holding Limited (SLBT)
NASDAQ (NMS) NASDAQ (NMS) Primary Summary
SL Science: A $1.15 Billion Valuation Built On Preclinical Promises
SL Science Holding Limited is rated Sell due to an unsustainable $1.15B valuation built on a strictly preclinical pipeline. SLBT's flagship Gamma Delta T cell therapy targets aggressive solid tumors but has not entered human trials, with a very low probability of success. With only $9M in cash, a $3.82M annual loss, and going-concern doubts, imminent dilution is almost certain without a major partnership.
SL Science Holding Limited (SLBT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has SL Science Holding Limited ever had a stock split?
SL Science Holding Limited Profile
| Trading Companies & Distributors Industry | Industrials Sector | William Wang CEO | NASDAQ (NMS) Exchange | G8191L116 CUSIP |
| US Country | 15 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Horizon Space Acquisition II Corp. is a corporate entity incorporated in 2023, located in New York, New York. The primary aim of the company is to explore and eventually execute a business combination strategy. This includes a broad spectrum of potential transactions such as mergers, share exchanges, asset acquisitions, share purchases, recapitalizations, reorganizations, or other similar business combinations with one or more businesses or entities. With this approach, Horizon Space Acquisition II Corp. positions itself as a key player in facilitating significant corporate transformations, leveraging its strategic location and incorporation to engage with a diverse set of potential business opportunities.
Products and Services
As a company focused on mergers and acquisitions (M&A), Horizon Space Acquisition II Corp. does not offer traditional products or services. Instead, its offerings can be categorized based on the types of transactions it seeks to facilitate:
- Mergers
Horizon Space Acquisition II Corp. aims to serve as a conduit for merging companies, creating synergies and enhancing value for stakeholders. The company identifies and executes mergers where there is a strategic fit to improve market share, operational efficiency, or enter new markets.
- Share Exchanges
This involves the acquisition of one company by another through the exchange of shares. Horizon Space Acquisition II Corp. works to identify opportunities where share exchange can serve as a viable method for companies to achieve mutual growth objectives, diversification, or consolidation strategies.
- Asset Acquisitions
Focuses on the acquisition of valuable assets from other companies, be it for strategic expansion, obtaining proprietary technology, or enhancing the company’s portfolio. Horizon Space Acquisition II Corp. seeks to identify and acquire assets that align with their investment strategy, providing a pathway to rapid growth or diversification.
- Share Purchases
Horizon Space Acquisition II Corp. may engage in direct share purchase agreements to gain control or significant influence over target companies. This strategy enables the company to rapidly enter new markets or sectors by acquiring existing operations and customer bases.
- Recapitalizations
This service involves restructuring a company's capital structure to achieve a more stable or optimal financial position. Horizon Space Acquisition II Corp. offers expertise in recapitalizations that can help companies reduce debt, issue equity, or reorganize operations for improved financial health and operational efficiency.
- Reorganizations
Horizon Space Acquisition II Corp. provides strategic guidance and implementation services for businesses undergoing reorganization. This can involve changes in corporate structure, business model transformation, or operational adjustments to adapt to market changes or overcome financial challenges.
Contact Information
